| Date Filed | Type | Description |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 10/04/2022 |
4
| Kilcoyne Adrian (See Remarks) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 66,226 options to buy
@ $2.19, valued at
$145k
|
|
| 10/04/2022 |
3
| Kilcoyne Adrian (See Remarks) has filed a Form 3 on Celularity Inc |
| 07/29/2022 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 537,164 options to buy
@ $0.38, valued at
$204.1k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2022 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 38,411 options to buy
@ $2.99, valued at
$114.8k
|
|
| 01/04/2022 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 34,500 options to buy
@ $3.72, valued at
$128.3k
|
|
| 11/26/2021 |
4
| Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Disposed/sold 5,863 options to buy
@ $5.93, valued at
$34.8k
|
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |